利用对质母细胞瘤微环境的天生的免疫力
Wenbo Zhang1, Wanhong Zhang2, Henghao Wu2
1Department of Neurology, Kaifeng Central Hospital, Xinxiang Medical University, Kaifeng, China.
Frontiers in immunology
|August 11, 2025
概括
质母细胞瘤 (glioblastoma) 是一个
科学领域:
- 神经瘤学和免疫学,专注于质母细胞瘤 (GBM) 中的瘤微环境 (TME).
背景情况:
- 质母细胞瘤 (GBM) 呈现出由天生的免疫细胞驱动的高度免疫抑制的瘤微环境 (TME).
- 关键的参与者包括瘤相关的巨细胞 (TAMs),微质细胞和骨髓性衍生抑制细胞 (MDSCs),这些细胞促进瘤生长和免疫逃避.
- 这些细胞抑制了适应性T细胞反应,阻碍了当前免疫治疗的有效性.
研究的目的:
- 审查先天免疫在质母细胞瘤发展中的关键作用.
- 探索针对GBM TME内天生的免疫细胞的新型治疗策略.
- 讨论克服治疗耐药性的组合方法.
主要方法:
- 文献综述总结了关于GBM先天免疫力的现有研究.
- 分析天生的免疫细胞对免疫抑制有所贡献的机制.
- 探索新兴的治疗目标和组合策略.
主要成果:
- 天生的免疫细胞,特别是TAMs,微质细胞和MDSCs,是GBM免疫抑制TME的核心.
- 这些细胞分泌免疫抑制性细胞因子 (例如IL-10,TGF-β) 并重编程新陈代谢,抑制抗瘤免疫力.
- 针对这些天生的免疫成分为治疗干预提供了潜在的潜力.
结论:
- 通过TAM再极化,MDSC枯竭或NK细胞激活来调节先天免疫,可以重塑GBM TME.
- 将天生的免疫向策略与检查点封锁,病毒治疗或代谢干预相结合,显示出有前途.
- 这些综合方法可以克服质母细胞瘤的治疗阻力.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


